A Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogen Combinations for Treatment of Vasomotor Symptoms Associated With Menopause
Sponsor study identifier
interventional
325
1 country
7
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 2007
Actual (reported)The purpose of this study is to determine whether bazedoxifene/conjugated estrogens combinations are effective in the treatment of moderate to severe vasomotor symptoms associated with menopause.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
October 5, 2005
Actual (reported)October 7, 2005
Actual (reported)February 2007
Actual (reported)Number and severity of moderate and severe hot flashes at week 4 and at week 12, as reported daily on subject diary cards.
Breast pain throughout the 12 week study, as reported daily on subject diary cards. Sleep scales and sleep quantity at week 4 and week 12, as indicated on a subject-completed questionnaire.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Phoenix, Arizona, 85105, United States
Fort Myers, Florida, 33916, United States
North Port Richey, Florida, 34652, United States
Scarborough, Maine, 04074, United States
Albuquerque, New Mexico, 87102, United States
Winston-Salem, North Carolina, 27103, United States
Pottstown, Pennsylvania, 19464, United States
Archer DF, Freeman EW, Komm BS, Ryan KA, Yu CR, Mirkin S, Pinkerton JV. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. J Womens Health (Larchmt). 2016 Nov;25(11):1102-1111. doi: 10.1089/jwh.2015.5558. Epub 2016 Sep 27.
Medical Monitor
Wyeth is now a wholly owned subsidiary of Pfizer
First Submitted
October 5, 2005
First Posted
October 7, 2005
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
February 2007
Actual (reported)Contact the study team to confirm eligibility.
Last Updated
December 28, 2007
Record last verified: 2007-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: